{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:36:54Z","timestamp":1794433014883,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T00:00:00Z","timestamp":1734998400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>With the clinical integration of sugammadex, a selective relaxant-binding agent, the approach to reversing neuromuscular blockade is revolutionized. Despite its efficacy, sugammadex\u2019s adverse reactions range from mild symptoms to severe cases, including anaphylaxis and coagulopathy. Assessing the nature of these reactions using the Food and Drug Administration\u2019s Adverse Event Reporting System (FAERS) database is vital for safe anesthetic practice. This study aimed to analyze and categorize the adverse drug events (ADEs) related to sugammadex reported in the FAERS database and evaluate the potential safety signals since its market entry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>This systematic analysis study extracted and filtered FAERS data pertinent to sugammadex from its introduction in 2008 to the last quarter of 2023 and employed standardized MedDRA terminologies for ADE re-encoding. The Reporting Odds Ratio (ROR) method analyzed ADE signal strength, identifying significant cardiovascular, allergic, and neurological signals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>From 1505 patient reports totaling 3562 ADEs, prominent adverse reaction signals were detected for respiratory and cardiovascular systems and severe allergic and neurological effects. Specific signals, including laryngospasm, bronchospasm, and Disseminated Intravascular Coagulation (DIC), among others, were highlighted and necessitated urgent clinical attention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Sugammadex is associated with a spectrum of adverse reactions, some of which demand increased clinical surveillance, particularly in older and pediatric populations. The significance of allergic reactions, airway spasms, and coagulation events indicates the need for precise risk assessment and vigilant monitoring during clinical use.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000002194","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T14:01:58Z","timestamp":1734962518000},"page":"1988-1994","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":41,"title":["Systematic analysis of sugammadex-related adverse drug reaction signals using FAERS database"],"prefix":"10.1097","volume":"111","author":[{"given":"Hongtao","family":"Liu","sequence":"first","affiliation":[{"name":"Guangxi Health Science College, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyu","family":"Li","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Yan","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaopeng","family":"Ming","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Guangxi Medical University, Nanning, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2]]},"reference":[{"key":"R1-20250224","first-page":"57","article-title":"Sugammadex","volume":"15","author":"Karalapillai","year":"2013","journal-title":"Crit Care Resusc"},{"key":"R2-20250224","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","article-title":"Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis","volume":"132","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"key":"R4-20250224","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2174\/1381612825666190704101145","article-title":"Sugammadex for reversal of neuromuscular blockade: uses and limitations","volume":"25","author":"Hawkins","year":"2019","journal-title":"Curr Pharm Des"},{"key":"R5-20250224","doi-asserted-by":"crossref","first-page":"441","DOI":"10.17085\/apm.2019.14.4.441","article-title":"Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey","volume":"14","author":"Kim","year":"2019","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R6-20250224","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bja.2020.01.003","article-title":"Anaphylaxis to sugammadex: should we be concerned by the Japanese experience?","volume":"124","author":"Savic","year":"2020","journal-title":"Br J Anaesth"},{"key":"R7-20250224","doi-asserted-by":"crossref","first-page":"191","DOI":"10.17085\/apm.21096","article-title":"Adverse events of sugammadex that occurred in a Korean population","volume":"17","author":"Han","year":"2022","journal-title":"Anesth Pain Med (Seoul)"},{"key":"R8-20250224","first-page":"e34728","article-title":"Adverse effects of sugammadex on the cardiovascular system","volume":"15","author":"Kadiyala","year":"2023","journal-title":"Cureus"},{"key":"R10-20250224","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf"},{"key":"R11-20250224","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/pds.5624","article-title":"Sensitivity and specificity in signal detection with the reporting odds ratio and the information component","volume":"32","author":"Trillenberg","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R12-20250224","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/pds.1742","article-title":"Quantitative signal detection using spontaneous ADR reporting","volume":"18","author":"Bate","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R13-20250224","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmjqs-2015-004411","article-title":"SQUIRE 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process","volume":"25","author":"Ogrinc","year":"2016","journal-title":"BMJ Qual Saf"},{"key":"R14-20250224","doi-asserted-by":"crossref","first-page":"644","DOI":"10.14423\/SMJ.0000000000001304","article-title":"Sugammadex reduces PACU recovery time after abdominal surgery compared with neostigmine","volume":"114","author":"Deng","year":"2021","journal-title":"South Med J"},{"key":"R15-20250224","doi-asserted-by":"crossref","first-page":"e010643","DOI":"10.1136\/bmjopen-2015-010643","article-title":"Overview of phase IV clinical trials for postmarket drug safety surveillance: a status report from the ClinicalTrials.gov registry","volume":"6","author":"Zhang","year":"2016","journal-title":"BMJ Open"},{"key":"R16-20250224","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcyt.2023.06.005","article-title":"Post-marketing authorisation safety and efficacy surveillance of advanced therapy medicinal products in Brazil, the European Union, the United States and Japan","volume":"25","author":"Gomes","year":"2023","journal-title":"Cytotherapy"},{"key":"R17-20250224","doi-asserted-by":"crossref","first-page":"e01725","DOI":"10.1213\/XAA.0000000000001725","article-title":"Sugammadex-induced anaphylactic shock reversed with short-term continuous veno-venous hemodiafiltration: a case report","volume":"17","author":"Dichtwald","year":"2023","journal-title":"A A Pract"},{"key":"R18-20250224","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s00540-016-2280-4","article-title":"A suspected case of rocuronium-sugammadex complex-induced anaphylactic shock after cesarean section","volume":"31","author":"Yamaoka","year":"2017","journal-title":"J Anesth"},{"key":"R19-20250224","first-page":"986","article-title":"Anaphylaxis sugammadex-induced in a pediatric patient","volume":"68","author":"Joyanes-Romo","year":"2021","journal-title":"Rev Alerg Mex"},{"key":"R21-20250224","doi-asserted-by":"crossref","first-page":"152","DOI":"10.18176\/jiaci.0719","article-title":"Sugammadex-induced anaphylaxis: 2 case reports","volume":"32","author":"Lazo Uslar","year":"2022","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R22-20250224","first-page":"1043","article-title":"Sugammadex versus neostigmine for reversal of residual neuromuscular blocks after surgery: a retrospective cohort analysis of postoperative side effects","volume":"134","author":"Ruetzler","year":"2022","journal-title":"Anesth Analg"},{"key":"R23-20250224","doi-asserted-by":"crossref","first-page":"287","DOI":"10.17245\/jdapm.2023.23.5.287","article-title":"Sugammadex-induced bronchospasm: a case report","volume":"23","author":"Kim","year":"2023","journal-title":"J Dent Anesth Pain Med"},{"key":"R24-20250224","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1097\/MJT.0000000000001390","article-title":"Sugammadex-associated bronchospasm","volume":"29","author":"Trivedi","year":"2021","journal-title":"Am J Ther"},{"key":"R25-20250224","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jclinane.2019.01.043","article-title":"Sugammadex and laryngospasm","volume":"56","author":"Wu","year":"2019","journal-title":"J Clin Anesth"},{"key":"R26-20250224","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/anae.13816","article-title":"Sugammadex and laryngospasm","volume":"72","author":"Greenaway","year":"2017","journal-title":"Anaesthesia"},{"key":"R27-20250224","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jclinane.2017.06.017","article-title":"The combination of sugammadex and desflurane may increase the risk of bronchospasm during general anesthesia","volume":"41","author":"Eskander","year":"2017","journal-title":"J Clin Anesth"},{"key":"R28-20250224","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.bja.2019.04.001","article-title":"Sugammadex-induced bronchospasm during desflurane anaesthesia","volume":"123","author":"Baronos","year":"2019","journal-title":"Br J Anaesth"},{"key":"R29-20250224","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1016\/j.jfma.2022.04.017","article-title":"Sugammadex reversal of muscle relaxant blockade provided less post-anesthesia care unit adverse effects than neostigmine\/glycopyrrolate","volume":"121","author":"Chang","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"R30-20250224","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1213\/ANE.0000000000006939","article-title":"Association of intravenous neostigmine and anticholinergics or sugammadex with postoperative delirium: a retrospective cohort study","volume":"140","author":"R\u00f6ssler","year":"2024","journal-title":"Anesth Analg"},{"key":"R31-20250224","doi-asserted-by":"crossref","first-page":"1054597","DOI":"10.1155\/2016\/1054597","article-title":"Postoperative delirium in elderly patients undergoing hip fracture surgery in the sugammadex era: a retrospective study","volume":"2016","author":"Oh","year":"2016","journal-title":"Biomed Res Int"},{"key":"R32-20250224","first-page":"736790","article-title":"Emergence in elderly patient undergoing general anesthesia with xenon","volume":"2013","author":"Sanfilippo","year":"2013","journal-title":"Case Rep Anesthesiol"},{"key":"R33-20250224","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5414\/CP203858","article-title":"The mode of action of sugammadex on coagulation","volume":"59","author":"Kruithof","year":"2021","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R34-20250224","first-page":"746","article-title":"Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment","volume":"55","author":"Min","year":"2017","journal-title":"Int J Clin Pharmacol Ther"},{"key":"R35-20250224","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1053\/j.jvca.2020.08.069","article-title":"Sugammadex for fast-track surgery in children undergoing cardiac surgery: a randomized controlled study","volume":"35","author":"Li","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R36-20250224","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/pan.14370","article-title":"Sugammadex for reversal of neuromuscular blockade in pediatric patients: results from a phase IV randomized study","volume":"32","author":"Voss","year":"2022","journal-title":"Paediatr Anaesth"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:32:33Z","timestamp":1786033953000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000002194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000002194","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,24]]},"assertion":[{"value":"2024-07-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}